Kissei Pharmaceutical Co Statistics
Want to see JP:4547 full AI Analyst Report?
Kissei Pharmaceutical Co (4547) Stock Statistics & Valuation Metrics
Total Valuation
Kissei Pharmaceutical Co has a market cap or net worth of JPY 149.70B. The enterprise value is JPY 105.33B.
- Market Cap
- JPY 149.70B
- Enterprise Value
- JPY 105.33B
Share Statistics
Kissei Pharmaceutical Co has 46,541,985 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 46,541,985
- Owned by Insiders
- ―
- Owned by Institutions
- 8.49%
Financial Efficiency
Kissei Pharmaceutical Co’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is -0.95%.
- Return on Equity (ROE)
- 0.06
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- -0.95%
- Return on Capital Employed (ROCE)
- -0.01
- Revenue Per Employee
- 54.54M
- Profits Per Employee
- 7.72M
- Employee Count
- 1,786
- Asset Turnover
- 0.35
- Inventory Turnover
- 2.02
Valuation Ratios
The current PE Ratio of Kissei Pharmaceutical Co is 14.04. Kissei Pharmaceutical Co’s PEG ratio is -0.66.
- PE Ratio
- 14.04
- PS Ratio
- 1.63
- PB Ratio
- 0.71
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -0.66
Income Statement
In the last 12 months, Kissei Pharmaceutical Co had revenue of 97.41B and earned 13.78B in profits. Earnings per share was 331.53.
- Revenue
- 97.41B
- Gross Profit
- 45.82B
- Operating Income
- -2.93B
- Pretax Income
- 16.89B
- Net Income
- 13.78B
- EBITDA
- 21.56B
- Earnings Per Share (EPS)
- 331.53
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Kissei Pharmaceutical Co pays an annual dividend of JPY 65.00, resulting in a dividend yield of 5.73%
- Dividend Per Share
- JPY 65.00
- Dividend Yield
- 5.73%
- Payout Ratio
- 26.83%
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 6.91%
Stock Price Statistics
- Beta
- 0.60
- 52-Week Price Change
- -8.72%
- 50-Day Moving Average
- 3824.28
- 200-Day Moving Average
- 4095.82
- Relative Strength Index (RSI)
- 40.65
- Average Volume (3m)
- 73.55K
Important Dates
Kissei Pharmaceutical Co upcoming earnings date is Feb 02, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 10, 2026
- Next Earnings Date
- Feb 02, 2027
- Ex-Dividend Date
- Sep 30, 2026
Financial Position
Kissei Pharmaceutical Co as a current ratio of 5.30, with Debt / Equity ratio of 0.54%
- Current Ratio
- 5.30
- Quick Ratio
- 4.12
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -1.29
- Interest Coverage Ratio
- -104.50
Taxes
In the past 12 months, Kissei Pharmaceutical Co has paid 2.93B in taxes.
- Income Tax
- 2.93B
- Effective Tax Rate
- 0.17
Enterprise Valuation
Kissei Pharmaceutical Co EV to EBITDA ratio is 9.28, with an EV/FCF ratio of 0.00.
- EV to Sales
- 1.33
- EV to EBITDA
- 9.28
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Kissei Pharmaceutical Co has JPY 52.95B in cash and marketable securities with JPY 1.72B in debt, giving a net cash position of JPY 51.24B billion.
- Cash & Marketable Securities
- JPY 52.95B
- Total Debt
- JPY 1.72B
- Net Cash
- JPY 51.24B
- Net Cash Per Share
- JPY 1,100.86
- Tangible Book Value Per Share
- JPY 5,507.39
Margins
Gross margin is 46.19%, with operating margin of 5.77%, and net profit margin of 11.52%.
- Gross Margin
- 46.19%
- Operating Margin
- 5.77%
- Pretax Margin
- 14.57%
- Net Profit Margin
- 11.52%
- EBITDA Margin
- 14.38%
- EBIT Margin
- 9.47%
Analyst Forecast
The average price target for Kissei Pharmaceutical Co is JPY 4,166.67, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- JPY 4,166.67
- Price Target Upside
- 13.69% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 3
- Revenue Growth Forecast
- 5.87%
- EPS Growth Forecast
- -21.24%
Scores
- Smart Score
- ―
- AI Score
- 64
